PRNewswire - November 25, 2003

NEW YORK, Nov. 25 /PRNewswire/ -- On the eve of World AIDS Day, Bristol- Myers Squibb Company (NYSE: BMY) announced today the next phase of SECURE THE FUTURE(R) with the allocation of six new program grants totaling $30 million.

These grants are part of the ongoing $115 million commitment made by Bristol- Myers Squibb and the Bristol-Myers Squibb Foundation as part of the SECURE THE FUTURE initiative, the first significant and largest corporate commitment to fight HIV/AIDS in Africa. The program focuses on sub-Saharan Africa, where nearly 70 percent of people infected with HIV/AIDS worldwide -- and 80 percent of the children -- live.

"SECURE THE FUTURE is establishing a new paradigm for combating the AIDS pandemic in Africa," said Dr. Pearl Ntsekhe, director, Disease Control Division, Lesotho Ministry of Health and Social Welfare. "The unique approach of offering both community and medical services is critically important to efforts to stem the devastation of this disease."

"Through SECURE THE FUTURE, Bristol-Myers Squibb is helping to lead the global fight against the HIV/AIDS pandemic," said Peter Dolan, chairman and chief executive officer, Bristol-Myers Squibb. "This is one of the greatest human tragedies of all time, and while making a substantial financial commitment is critically important, we have gone beyond that. Our program has pioneered the development of public-private partnerships that are benefiting the hardest-hit populations in Africa, especially women and children."

SECURE THE FUTURE is a five-year initiative to support projects that help women and children affected and infected by HIV/AIDS. To date, the initiative has provided grants totaling $96 million, including this new allocation, to more than 150 programs in nine countries in southern and western Africa. The goal is to develop sustainable models in resource-limited settings for community outreach and education, as well as medical research and care. The program's focus has been to address the region's most significant needs including local training and support for community-based initiatives, building internal resources and infrastructure and implementing modern science within a local context.

The six new grants will fund programs at community and medical centers that incorporate key learnings from other SECURE THE FUTURE programs. The new programs will be launched in Botswana, Namibia, Lesotho and Swaziland, as well as South Africa -- the area of the world most devastated by the HIV/AIDS pandemic.

Progress Through Partnerships

SECURE THE FUTURE programs are guided by unique partnerships among Bristol-Myers Squibb, national ministries of health, non-governmental organizations (NGOs), community-based medical and educational organizations, and faith-based organizations (FBOs). Through these partnerships, SECURE THE FUTURE focuses on supporting rural communities challenged with limited resources and with needs that have not been addressed by other programs.

"The relationships we forged through SECURE THE FUTURE are as important as the funds we received," said Reverend Edward Baralemwa, executive secretary, Pan African Christian AIDS Network (PACANet). "Our partners helped us with process and procedure improvements, they showed us how to achieve our objectives better and they enhanced the well-being of our entire organization."

The newly issued grants support programs that reflect the best examples of this partnership model. One program will support a partnership program in the isolated Caprivi region of Namibia with a focus on prevention of mother-to- child transmission of HIV/AIDS. The program will establish support group networks and nutrition services and provide care through a new voluntary counseling and testing center.

Another new SECURE THE FUTURE grant that also is designed to help address the problem of mother-to-child transmission of HIV in Swaziland will mobilize people through door-to-door outreach -- and build infrastructure through a community initiative that includes volunteers, buddies/mentors and community- based activities.

Another SECURE THE FUTURE grant will fund the country of Lesotho's first center to provide an antiretroviral therapy program in the Maseru district. The aim is to deliver equitable access to quality care and support.

"Bristol-Myers Squibb understands that developing and providing antiviral drugs are only part of the formula for success in changing the course of the AIDS pandemic in Africa," said John McGoldrick, executive vice president, Bristol-Myers Squibb. "SECURE THE FUTURE seeks to provide medical treatment to resource-limited communities as well as to educate people on ways to prevent further transmission of the virus and provide support to those infected and affected by the disease."

Leveraging Lessons Learned

Since its inception, a key principle of SECURE THE FUTURE has been to support innovative community-based programs that have the potential to be replicated and expanded cost-effectively.

"The success of the SECURE THE FUTURE model results from listening to the needs of community members and empowering them to develop the solution," said John Damonti, president, Bristol-Myers Squibb Foundation. "We don't tell communities what to do or how to do it, and we don't just provide funds or do the work for them. We are on the ground in Africa working side-by-side with local organizations to help them build and define their future."

The Future

SECURE THE FUTURE has engaged Family Health International (FHI), an organization working worldwide to address comprehensive health issues in resource-poor settings, along with local monitoring and evaluation specialists to develop a framework for measuring the success of the new grant programs. These efforts will help ensure that metrics are incorporated at the design stage of new initiatives and that existing resources are invested in the most effective programs.

"We were the first ones in Africa trying to do something no one else has, so it took us a while to develop effective ways to deal with the pandemic. But at this we have learned how to create and support programs with successful treatment outcomes coupled with strong community support for people living with HIV/AIDS," said McGoldrick. "Our company will continue to stand behind our mission by developing programs that extend and enhance human life and hope that others will join us, because despite all efforts there still remains much, much more to be done if we are to stem the tide of this epidemic." Bristol-Myers Squibb is a global pharmaceutical and related health care products company whose mission is to extend and enhance human life.

SECURE THE FUTURE(R) - Key Learnings

Four short years after Bristol-Myers Squibb Company first set out to be an active partner in addressing the HIV/AIDS crisis on the African front, the company has learned that to make a difference and mitigate the impact of HIV/AIDS requires more than a significant financial commitment. While its landmark program, SECURE THE FUTURE(R), was the first to successfully face the issue head-on, Bristol-Myers Squibb also was the first U.S. company to try and address a public health crisis in sub-Saharan Africa - a region with a vastly different economy, culture, government and view of medicine.

Early challenges led to learnings that continue to influence the priorities, strategies and ongoing successes of the program.

Diverse Needs

One of most significant and immediate challenges was understanding and responding to local needs. Even geographically close regions in Africa may have vastly different cultural or socio-economic backgrounds. The chronic nature of HIV/AIDS is underestimated and it is even harder without the basic needs of life. Initially, Bristol-Myers Squibb tried to develop programming based on known public health models and not localized needs. The company soon discovered the need to change its approach, so that it was closely aligned with current governmental AIDS policy and priorities.

Only with support and guidance from within the countries, were the supported programs likely to be effective, respond to the needs of the local culture and ultimately become sustainable.

Finding Solutions

Early on, Bristol-Myers Squibb saw the need to redirect efforts. To achieve sustainable change, the company needed to reach out to local organizations and, with their important help, identify workable solutions. Through this process it became clear that the keys to success were to:

-- Identify community programs that work locally and provide the support, guidance and training needed to grow/expand.

-- Build capacity of organizations to plan, implement and monitor programs so that successful programs continue to receive support.

-- Provide resources to increase infrastructure (healthcare, laboratory services, research equipment, transportation).

-- Address other factors driving the pandemic such as food security and poverty alleviation.

-- Implement science of the developed world and create synergies with traditional medicine.

Partnership for Success

SECURE THE FUTURE continues to embrace different forms of partnerships, recognizing these are essential to the overall success of the initiative. Partnerships involve more than financial commitments and can take the form of in-kind donations, skills transferring, best practice sharing, or evaluation. SECURE THE FUTURE has learned that partnering with other organizations such as foundations, faith-based organizations, non- governmental organizations, government agencies, medical institutions and corporations proves to be an invaluable way to provide economic, medical and psychological support to people living with HIV/AIDS. SECURE THE FUTURE continues to evolve as the epidemic evolves and new research and learnings become available.

In an effort to continue to learn from the program, Bristol-Myers Squibb has built ongoing independent evaluation mechanisms into the SECURE THE FUTURE program. Local monitoring and evaluation specialists, working under the direction of the Yale School of Public Health, are reviewing the impact of the program in Africa. The ultimate goal is to continue to shape and refine a philanthropic paradigm that other organizations, governments or foundations can use to develop sustainable and replicable solutions to the crisis in Africa.

SECURE THE FUTURE(R) - $30 Million New Grant Allocations

Since the launch of the groundbreaking SECURE THE FUTURE(R) initiative in 1999, the Bristol-Myers Squibb Company and the Bristol-Myers Squibb Foundation have funded more than 150 HIV/AIDS programs throughout the sub- Saharan region of Africa. To date, $66 million of the $115 million initiative has been allocated to programs focusing on the needs of women and children. SECURE THE FUTURE consults with African governments, medical communities, leaders and civil society organizations to identify the most pressing needs in the fight against HIV/AIDS in an effort to determine how to make the greatest, sustainable impact.

The commitment to stemming the tide of this terrible pandemic continues with six new community-based grants totaling $30 million. Based on key learnings from the past four years, these new grants will all work locally and provide support, guidance and training needed for growth; teach organizations how to apply for funding; provide resources to increase infrastructure; increase access to basic needs such as food and water; and implement science from the developed world within a local context. The six grants will be implemented in the following locations: Swaziland, Namibia, Lesotho, Botswana and South Africa.

Swaziland

Approximately 33.4 percent of the population in Swaziland has HIV/AIDS and the number of orphaned children is 35,000(1). With a focus on preventing mother-to-child transmissions, this pilot operational research and community-based program will mobilize people through door-to-door outreach - and build adequate infrastructure through volunteers and buddies/mentors as well as community-based activities. Additionally, the program will teach people about treatment options and provide essential nutritional and psychosocial support. Lastly, this program will pilot the provision of the "Prevention of Mother-to-Child Transmission Plus" concept including triple antiretroviral therapy for HIV-infected mothers, newborns and partners.

Namibia

There are 230,000 adults and children living with HIV/AIDS in Namibia and 47,000 children under the age of 15 who have lost their mother or father or both parents to AIDS(1). Recognizing the severity of this problem, a new SECURE THE FUTURE grant will help establish a program to address the problem of mother-to-child transmission in the Caprivi region.

The program goal is to reduce the prevalence of HIV infection and AIDS morbidity and mortality. SECURE THE FUTURE funds will help educate people and ultimately change perceptions and behaviors through targeted civic education programs; establish capacity-building initiatives such as support groups and nutrition services to those affected by HIV/AIDS; and provide care through a voluntary counseling and testing center.

Anticipated results include an introduction of "Prevention of Mother-to- Child Transmission Plus" and highly active antiretroviral therapy (HAART) in a hard to reach and extremely resource-limited region that share its borders with Botswana, Zambia, Angola and Zimbabwe.

Lesotho

Seventy-three thousand children are orphans because of HIV/AIDS in Lesotho. An estimated 31 percent of adults are living with HIV/AIDS and more than half of those are women(1). In an effort to provide much needed education and therapies, a SECURE THE FUTURE grant will fund the country's first center to provide an antiretroviral therapy program in the Maseru district. The aim is to deliver equitable access to quality care and support for those affected persons.

The program goals will be pursued through a tripartite partnership involving private, community-based and non-governmental organizations, and the public health sector. The focus of this initiative is to provide a learning center for a national rollout of antiretroviral therapy and strengthen the non-governmental organization sector, thus supporting those affected by HIV/AIDS.

Botswana

Nearly 40 percent of adults in Botswana live with HIV/AIDS and 26,000 people died of AIDS during 2001(1). To help people living with the condition, a national antiretroviral therapy program was developed. The government of Botswana welcomed SECURE THE FUTURE to extend a partnership to a remote and resource-limited Bobirwa sub-District of Bobonong to fast- track this community inclusion in the national rollout.

SECURE THE FUTURE partnered with the Ministries of Health and Local Government and a community-based association on this program to improve the quality of life for people living with HIV/AIDS through the provision of antiretroviral therapy. The initiative's key components include strengthening partnerships with clinics and the home-based care association; training healthcare and community workers; community mobilization; and involvement of buddies to increase adherence.

South Africa

SECURE THE FUTURE is working with provincial governments and non- governmental organizations to support two sites in rural areas and informal settlements as the country prepares for a national rollout of antiretroviral therapy. These sites will include community education; counseling and testing through existing structures; strengthening community support for prevention of mother-to-child transmission; and post-exposure prophylaxis for sexual survivors. This program will help the five million children and adults living with HIV/AIDS(1).

(1) "Epidemiological Fact Sheets on HIV/AIDS and Sexually Transmitted Infections: 2002 Update." UNAIDS, UNICEF and World Health Organization.

SOURCE Bristol-Myers Squibb Company

031125
PR031170

Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .